Kyntra Bio, Inc. SEC filings KYNB

Kyntra Bio, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 18, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (listing notice). The company's fiscal year ends on December 31.

Kyntra Bio, Inc. SEC filings
Form Description Filed Period
8-K Current report
Listing notice
Oct 6, 2026 Sep 30, 2026
8-K Current report
Officer or director change
Oct 1, 2026 Sep 30, 2026
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Aug 31, 2026 Aug 31, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Shareholder vote results
Jun 16, 2026 Jun 12, 2026
8-K Current report
Other events
Jun 9, 2026 Jun 2, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 27, 2026 —
DEF 14A Proxy statement Apr 27, 2026 Jun 12, 2026
8-K Current report
Listing notice
Apr 9, 2026 Apr 2, 2026
10-K Annual report Mar 16, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 16, 2026 Mar 16, 2026
8-K Current report
Bylaw or fiscal year change, Other events
Jan 7, 2026 Jan 7, 2026
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
8-K Current report
Other events
Nov 6, 2025 Nov 6, 2025
8-K Current report
Acquisition or sale of assets
Sep 5, 2025 Aug 29, 2025
8-K Current report
Other events
Sep 2, 2025 Aug 29, 2025
8-K Current report
Other events
Aug 18, 2025 Aug 18, 2025
8-K Current report
Material agreement
Aug 14, 2025 Aug 12, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
8-K Current report
Material agreement
Jul 14, 2025 Jul 14, 2025
8-K Current report
Agreement ended
Jun 13, 2025 Jun 12, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jun 12, 2025 Jun 10, 2025
8-K Current report
Material agreement, Officer or director change, Shareholder vote results
Jun 9, 2025 Jun 4, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 4, 2025
PRE 14A Preliminary proxy statement Apr 17, 2025 Jun 4, 2025
8-K Current report
Bylaw or fiscal year change
Apr 4, 2025 Apr 2, 2025
8-K Current report
Regulation FD disclosure
Mar 31, 2025 Mar 28, 2025
8-K Current report
Material agreement
Mar 28, 2025 Mar 28, 2025
10-K Annual report Mar 17, 2025 Dec 31, 2024
8-K Current report
Results of operations, Listing notice
Mar 17, 2025 Mar 12, 2025
8-K Current report
Material agreement
Feb 24, 2025 Feb 24, 2025
424B5 Prospectus supplement Feb 24, 2025 —
8-K Current report
Material agreement, Results of operations, Officer or director change, Regulation FD disclosure
Feb 20, 2025 Feb 19, 2025
8-K Current report
Officer or director change
Dec 16, 2024 Dec 16, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Agreement ended
Oct 3, 2024 Sep 27, 2024
8-K Current report
Listing notice
Sep 16, 2024 Sep 12, 2024
8-K Current report
Officer or director change
Sep 13, 2024 Sep 12, 2024
8-K Current report
Officer or director change
Sep 6, 2024 Aug 30, 2024
S-8 Employee stock plan registration Aug 7, 2024 —
8-K Current report
Exit or restructuring costs
Aug 7, 2024 Aug 2, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
EFFECT Filing Jul 10, 2024 —
CORRESP Letter to the SEC Jul 9, 2024 —
UPLOAD Letter from the SEC Jul 9, 2024 —
S-3 Shelf registration Jun 28, 2024 —
8-K Current report
Other events
Jun 26, 2024 Jun 26, 2024
8-K Current report
Shareholder vote results
Jun 7, 2024 Jun 5, 2024
10-Q Quarterly report May 6, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 6, 2024 May 6, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 24, 2024 —
DEF 14A Proxy statement Apr 24, 2024 Jun 5, 2024
10-K Annual report Feb 26, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 26, 2024 Feb 26, 2024
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 6, 2023 Nov 6, 2023
8-K Current report
Listing notice
Oct 27, 2023 Oct 24, 2023
8-K Current report
Officer or director change
Oct 6, 2023 Oct 2, 2023
8-K Current report
Officer or director change
Sep 6, 2023 Aug 31, 2023
8-K Current report
Other events
Aug 29, 2023 Aug 29, 2023
S-8 Employee stock plan registration Aug 7, 2023 —
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 7, 2023 Aug 7, 2023
8-K Current report
Officer or director change, Other events
Jul 25, 2023 Jul 21, 2023
8-K Current report
Exit or restructuring costs
Jul 19, 2023 Jul 14, 2023
8-K Current report
Other events
Jun 26, 2023 Jun 26, 2023
8-K Current report
Shareholder vote results
Jun 9, 2023 Jun 7, 2023
8-K Current report
Other events
Jun 7, 2023 Jun 7, 2023
DEFA14A Additional proxy material May 31, 2023 —
8-K Current report
Other events
May 18, 2023 May 18, 2023
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 8, 2023 May 8, 2023
8-K Current report
Material agreement, New debt
May 1, 2023 Apr 29, 2023
ARS Annual report to shareholders Apr 27, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 27, 2023 —
DEF 14A Proxy statement Apr 27, 2023 —
424B5 Prospectus supplement Feb 27, 2023 —
10-K Annual report Feb 27, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 27, 2023 Feb 27, 2023
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 7, 2022 Nov 7, 2022
S-8 Employee stock plan registration Aug 8, 2022 —
S-3ASR Automatic shelf registration Aug 8, 2022 —
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
8-K Current report
Shareholder vote results
Jun 17, 2022 Jun 16, 2022
8-K Current report
Officer or director change
Jun 8, 2022 Jun 5, 2022
10-Q Quarterly report May 9, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 9, 2022 May 9, 2022
UPLOAD Letter from the SEC May 3, 2022 —
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 16, 2022
10-K/A Amended annual report Mar 4, 2022 Dec 31, 2021
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 28, 2022 Feb 28, 2022
CORRESP Letter to the SEC Feb 11, 2022 —
UPLOAD Letter from the SEC Feb 2, 2022 —
CORRESP Letter to the SEC Jan 20, 2022 —
UPLOAD Letter from the SEC Jan 5, 2022 —
CORRESP Letter to the SEC Dec 16, 2021 —
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
UPLOAD Letter from the SEC Nov 8, 2021 —
8-K Current report
Officer or director change
Aug 27, 2021 Aug 24, 2021
8-K Current report
Other events
Aug 20, 2021 Aug 19, 2021
8-K Current report
Officer or director change
Aug 16, 2021 Aug 14, 2021
8-K Current report
Other events
Aug 11, 2021 Aug 11, 2021
S-8 Employee stock plan registration Aug 9, 2021 —
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
8-K Current report
Material agreement
Jul 20, 2021 Jul 19, 2021
8-K Current report
Other events
Jun 25, 2021 Jun 25, 2021
8-K Current report
Material agreement
Jun 17, 2021 Jun 17, 2021
8-K Current report
Material agreement
Jun 7, 2021 Jun 1, 2021
8-K Current report
Shareholder vote results
May 27, 2021 May 26, 2021
8-K Current report
Regulation FD disclosure
May 14, 2021 May 12, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
8-K Current report
Officer or director change
Apr 13, 2021 Apr 9, 2021
DEFA14A Additional proxy material Apr 13, 2021 —
DEF 14A Proxy statement Apr 13, 2021 May 26, 2021
8-K Current report
Regulation FD disclosure
Apr 7, 2021 Apr 6, 2021
8-K Current report
Other events
Apr 6, 2021 Apr 6, 2021
SEC STAFF LETTER Filing Mar 29, 2021 —
10-K Annual report Mar 1, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 1, 2021 Mar 1, 2021
SEC STAFF LETTER Filing Mar 1, 2021 —
8-K Current report
Material agreement
Jan 27, 2021 Jan 13, 2021
8-K Current report
Other events
Dec 18, 2020 Dec 18, 2020
8-K Current report
Officer or director change
Dec 1, 2020 Nov 27, 2020
8-K Current report
Material agreement
Nov 12, 2020 Nov 9, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
CT ORDER Filing Sep 18, 2020 —
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Officer or director change
Aug 6, 2020 Aug 5, 2020
8-K Current report
Material agreement
Jul 10, 2020 Jul 8, 2020
8-K Current report
Officer or director change
Jun 23, 2020 Jun 23, 2020
8-K Current report
Shareholder vote results
Jun 9, 2020 Jun 4, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 23, 2020 —
DEF 14A Proxy statement Apr 23, 2020 Jun 4, 2020
8-K Current report
Material agreement
Mar 24, 2020 Mar 19, 2020
S-3ASR Automatic shelf registration Mar 2, 2020 —
10-K Annual report Mar 2, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 2, 2020 Mar 2, 2020
UPLOAD Letter from the SEC Feb 25, 2020 —
CORRESP Letter to the SEC Feb 21, 2020 —
UPLOAD Letter from the SEC Feb 14, 2020 —
8-K Current report
Officer or director change
Feb 13, 2020 Feb 11, 2020
8-K Current report
Other events
Feb 11, 2020 Feb 11, 2020
CORRESP Letter to the SEC Jan 31, 2020 —
8-K Current report
Other events
Jan 30, 2020 Jan 30, 2020
8-K Current report
Regulation FD disclosure
Jan 13, 2020 Jan 13, 2020
8-K Current report
Officer or director change, Other events
Jan 6, 2020 Jan 3, 2020
UPLOAD Letter from the SEC Dec 23, 2019 —
8-K Current report
Other events
Dec 23, 2019 Dec 23, 2019
8-K Current report
Officer or director change
Dec 16, 2019 Dec 9, 2019
CORRESP Letter to the SEC Dec 13, 2019 —
UPLOAD Letter from the SEC Dec 3, 2019 —
8-K Current report
Regulation FD disclosure
Dec 2, 2019 Dec 2, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 11, 2019
8-K Current report
Regulation FD disclosure
Nov 8, 2019 Nov 7, 2019
8-K Current report
Regulation FD disclosure
Nov 8, 2019 Nov 8, 2019
8-K Current report
Regulation FD disclosure
Oct 11, 2019 Oct 11, 2019
8-K Current report
Officer or director change
Oct 9, 2019 Oct 3, 2019
8-K Current report
Other events
Sep 26, 2019 Sep 26, 2019
8-K Current report
Other events
Sep 20, 2019 Sep 20, 2019
CT ORDER Filing Sep 4, 2019 —
CT ORDER Filing Sep 4, 2019 —
CT ORDER Filing Sep 4, 2019 —
CT ORDER Filing Sep 4, 2019 —
CT ORDER Filing Sep 4, 2019 —
CT ORDER Filing Sep 4, 2019 —
CT ORDER Filing Sep 4, 2019 —
8-K Current report
Officer or director change, Other events
Aug 26, 2019 Aug 26, 2019
8-K Current report
Other events
Aug 21, 2019 Aug 21, 2019
S-8 Employee stock plan registration Aug 9, 2019 —
10-Q Quarterly report Aug 8, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 8, 2019 Aug 8, 2019
8-K Current report
Other events
Jul 25, 2019 Jul 24, 2019
8-K Current report
Other events
Jul 22, 2019 Jul 22, 2019
8-K Current report
Regulation FD disclosure
Jun 28, 2019 Jun 28, 2019
8-K Current report
Officer or director change, Shareholder vote results
Jun 5, 2019 May 30, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KYNB (Nasdaq)
Fiscal year ends
December 31
Headquarters
San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
921299
Former names
FIBROGEN INC (until Jan 7, 2026)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.